Brooks, J. D., Comen, E. A., Reiner, A. S., Orlow, I., Leong, S. F., Liang, X., . . . Bernstein, J. L. (2018). CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. Breast Cancer Res.
Chicago-стиль цитированияBrooks, Jennifer D., et al. "CYP2D6 Phenotype, Tamoxifen, and Risk of Contralateral Breast Cancer in the WECARE Study." Breast Cancer Res 2018.
MLA-цитированиеBrooks, Jennifer D., et al. "CYP2D6 Phenotype, Tamoxifen, and Risk of Contralateral Breast Cancer in the WECARE Study." Breast Cancer Res 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.